Visit Neurobit Research

Revolutionizing Sleep and Population Health Research using Sleep as a Biomarker

Sleep Research

Sleep Disruption and Suicide Risk in Veterans: A New Study Examines the Link

In this blog, we delve into the critical intersection of sleep disruption and suicide risk, particularly among Veterans, as unveiled by a groundbreaking study led by Dr. Jennifer M. Primack and published in Sleep Advances. This research aims to shed light on the intricate link between sleep and suicide, underscoring the paramount importance of sleep health. Veterans, who face a disproportionately high risk of suicide, are the focus of this study, where sleep disruption, ranging from short sleep duration to nightmares, plays a pivotal role.

By Neurobit Health,

By Neurobit Health,

July 6, 2023

July 6, 2023

Share:

In a world where mental health issues are increasingly prevalent, understanding the factors that contribute to suicide risk is crucial. A groundbreaking study led by Dr. Jennifer M. Primack, published in Sleep Advances, reveals that sleep disruption significantly increases suicide risk, particularly among Veterans. Conducted at the Providence Veterans Affairs Medical Center and the Alpert Medical School of Brown University, the research aims to explore the mechanisms driving the link between sleep and suicide, emphasizing the importance of sleep health, a key focus area for Neurobit's innovative solutions.

Sleep disruption, ranging from short sleep duration, sleep discontinuity, nightmares, to insomnia, has been implicated in suicide risk. This issue is particularly critical among Veterans, who account for between 13.7% and 18% of all known suicides in the United States from 2001 to 2019. Despite the increasing rates of suicide among this population, the mechanistic pathways underlying the sleep-suicide link are less understood. This gap in knowledge aligns with Neurobit's mission to facilitate research and provide innovative solutions in the sleep health field.

The study involves 140 Veterans at acute suicide risk, either hospitalized for suicide attempt or ideation or identified as being at acute risk. The research employs actigraphy and ecological momentary assessment (EMA) data collection for 8 weeks, with follow-up assessments occurring at 2, 4, 6, 8, and 26 weeks. The primary outcome for aim 1 is suicide ideation severity and for the primary outcome for aim 2 is suicide behavior. The researchers hypothesize that sleep disruption increases the risk of suicidal thoughts and behaviors through momentary increases in impulsivity. They also propose that sleep disruption in the 48 hours and 7 days preceding a suicidal episode can predict an increased risk of suicidal behaviors.

The study's findings could significantly impact our understanding of the link between sleep disruption and suicide risk. By identifying the mechanisms through which sleep disruption increases suicide risk, the research could inform the development of more effective interventions for individuals at risk of suicide. Neurobit's innovative solutions, particularly in sleep health, could play a crucial role in these interventions.

While the study represents a significant step forward, it also highlights the challenges in the field. The dynamic nature of the factors involved, including sleep disruption, emotional reactivity, and impulsivity, requires sophisticated data collection and analysis methods. Neurobit's solutions can help overcome these challenges by providing accurate and comprehensive sleep data.

Neurobit offers a suite of innovative products that can contribute to addressing these challenges:

  1. Neurobit Score: An AI and deep learning platform for accurate sleep event labeling. This can aid in the precise measurement of sleep disruption, a key factor in the study.

  2. Z3 Pulse: A wearable ECG device for comprehensive sleep reports and personalized guidance. This can provide valuable data for understanding the link between sleep and suicide risk.

  3. Neurobit Hub: A platform for collecting and analyzing extensive datasets, promoting the discovery of novel biomarkers and sleep-centric treatment strategies.


Concluding Remarks:

The study underscores the importance of understanding the link between sleep disruption and suicide risk, particularly among Veterans. Neurobit's technology can play a crucial role in addressing this issue by providing accurate and comprehensive sleep data, which can inform the development of effective interventions.

We invite you to learn more about Neurobit's innovative solutions and how they can contribute to addressing the challenges in sleep health research. For more information, please contact us: Research@Neurobit.com


Citation:

Primack, J. M., Quinn, M. J., Carskadon, M. A., Holman, C. S., Nazem, S., Kelsey, M. R., Fedorenko, E. J., McGeary, S., Brick, L. A., & McGeary, J. E. (2023). Longitudinal assessment of the sleep suicide link in Veterans: Methods and study protocol. Sleep Advances, 4(1), zpad025. https://doi.org/10.1093/sleepadvances/zpad025

Neurobit for Research

Neurobit for Research

Scalable solutions for physiological data collection, sleep scoring, and biomarker analysis for researchers

Scalable solutions for physiological data collection, sleep scoring, and biomarker analysis for researchers

Revolutionizing Sleep and Population Health Research using Sleep as a Biomarker

Revolutionizing Sleep and Population Health Research using Sleep as a Biomarker

Revolutionizing data management & analysis in sleep health and population health research.

Clinically validated, fully featured, AASM compliant, Cloud-AI powered automatic sleep scoring system.

Neurobit for Research

Scalable solutions for physiological data collection, sleep scoring, and biomarker analysis for researchers

© 2023 Neurobit Inc. All Rights Reserved.

Disclaimer: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE NOR PURPORTS TO DO SO. The contents of this website are meant purely for informational and educational purposes only. The website is not a substitute for medical advice, diagnosis, treatment or professional care. If you have or suspect you have a health problem, you should consult a doctor or a qualified healthcare provider. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

© 2023 Neurobit Inc. All Rights Reserved.

Disclaimer: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE NOR PURPORTS TO DO SO. The contents of this website are meant purely for informational and educational purposes only. The website is not a substitute for medical advice, diagnosis, treatment or professional care. If you have or suspect you have a health problem, you should consult a doctor or a qualified healthcare provider. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

Company

Our Products

Resources

Neurobit for

Partnerships

Email us at

More

© 2023 Neurobit Inc. All Rights Reserved.

Disclaimer: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE NOR PURPORTS TO DO SO. The contents of this website are meant purely for informational and educational purposes only. The website is not a substitute for medical advice, diagnosis, treatment or professional care. If you have or suspect you have a health problem, you should consult a doctor or a qualified healthcare provider. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.